Thrombosis and Haemostasis · 2010 · 68 citations · 17 references
MedicineHematologyInfectious DiseasesHemostasisHiv PreventionVirologyAntiretroviral TherapyCoagulation AbnormalitiesCoagulation DisordersDeep Vein ThrombosisThrombosisVenous ThromboembolismEndothelial Activation MarkersEndothelial Contribution To ThrombosisHiv Antiretroviral TherapyThrombotic Risk AssessmentVenous Thromboembolism AssessmentVenous Thromboembolism DetectionVenous Thrombus FormationVenous Ultrasound
An increased incidence of venous thromboembolism (VTE) is observed in human immunodeficiency virus (HIV)-infected patients. Only a limited number of studies described the effect of combined antiretroviral therapy (cART) on coagulation markers. In a prospective cohort study in cART-naive South African HIV-infected individuals the effect of initiating cART on markers of endothelial cell activation, coagulation and natural anticoagulation was studied. These markers were compared to the reference ranges for an HIV-uninfected control population recruited from hospital staff. A venous ultrasound of both legs was performed to detect asymptomatic deep venous thrombosis (DVT). A total number of 123 HIV-infected participants were included. The patients were predominantly black and severely immuno-compromised. The CD4 cell count increased and the HIV viral load decreased significantly after the initiation of cART (p<0.001). The median follow-up period was 7.2 (± 1.6) months. Laboratory testing before and after initiation of cART was completed by 86 patients. Before initiating cART significantly elevated von Willebrand factor and D-dimer levels, increased activated protein C sensitivity ratio (APCsr) and decreased total and free protein S and protein C levels were observed compared to HIV-negative controls. At follow-up all markers, except APCsr, improved towards the normal range for controls without showing complete normalisation. In a subgroup of 57 patients no asymptomatic DVT was found. Compared to the controls, abnormal levels of coagulation markers were observed in HIV-infected individuals before and after the initiation of cART. Most markers improved after starting cART, but remained significantly different from the controls, indicating a persistent disturbed haemostatic balance.
17
Elvin Geng, David R. Bangsberg, Nicolas Musinguzi et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2010 · 302 citations
Katja Wolf, Dimitrios Α. Tsakiris, Rainer Weber et al. · The Journal of Infectious Diseases · 2002 · 231 citations · Full text
Veterinary Medicine, Infectious Diseases, Pharmacotherapy +16